Bolt Biotherapeutics, Inc. (BOLT)
3.86
-0.04
(-1.03%)
USD |
NASDAQ |
Sep 08, 16:00
3.87
+0.01
(+0.26%)
After-Hours: 20:00
Bolt Biotherapeutics Market Cap : 7.436M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 7.436M |
| September 04, 2026 | 7.513M |
| September 03, 2026 | 7.503M |
| September 02, 2026 | 7.397M |
| September 01, 2026 | 7.84M |
| August 31, 2026 | 7.667M |
| August 28, 2026 | 7.349M |
| August 27, 2026 | 7.705M |
| August 26, 2026 | 7.551M |
| August 25, 2026 | 7.416M |
| August 24, 2026 | 7.204M |
| August 21, 2026 | 7.060M |
| August 20, 2026 | 6.164M |
| August 19, 2026 | 6.280M |
| August 18, 2026 | 6.121M |
| August 17, 2026 | 6.164M |
| August 14, 2026 | 6.453M |
| August 13, 2026 | 6.183M |
| August 12, 2026 | 6.646M |
| August 11, 2026 | 7.667M |
| August 10, 2026 | 7.686M |
| August 07, 2026 | 7.802M |
| August 06, 2026 | 7.437M |
| August 05, 2026 | 7.590M |
| August 04, 2026 | 7.590M |
| Date | Value |
|---|---|
| August 03, 2026 | 7.648M |
| July 31, 2026 | 7.667M |
| July 30, 2026 | 7.475M |
| July 29, 2026 | 7.398M |
| July 28, 2026 | 7.725M |
| July 27, 2026 | 7.637M |
| July 24, 2026 | 7.360M |
| July 23, 2026 | 7.321M |
| July 22, 2026 | 7.859M |
| July 21, 2026 | 7.725M |
| July 20, 2026 | 8.599M |
| July 17, 2026 | 8.494M |
| July 16, 2026 | 8.052M |
| July 15, 2026 | 8.090M |
| July 14, 2026 | 7.782M |
| July 13, 2026 | 7.264M |
| July 10, 2026 | 7.264M |
| July 09, 2026 | 7.648M |
| July 08, 2026 | 7.763M |
| July 07, 2026 | 7.782M |
| July 06, 2026 | 7.706M |
| July 02, 2026 | 7.782M |
| July 01, 2026 | 7.667M |
| June 30, 2026 | 7.398M |
| June 29, 2026 | 7.504M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 12.01B |
| Oncolytics Biotech, Inc. | 100.33M |
| Sangamo Therapeutics, Inc. | 66.66M |
| Sarepta Therapeutics, Inc. | 2.212B |
| Anixa Biosciences, Inc. | 98.38M |
Market Cap Related Metrics
| PS Ratio | 1.441 |
| PEG Ratio | -0.0107 |
| Price to Book Value | 0.5883 |
| Price | 3.86 |
| Earnings Yield | -425.9% |
| PEGY Ratio | -0.0107 |